Marion Chevrier

3.2k total citations · 1 hit paper
20 papers, 974 citations indexed

About

Marion Chevrier is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Marion Chevrier has authored 20 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Marion Chevrier's work include Breast Cancer Treatment Studies (3 papers), Ocular Oncology and Treatments (3 papers) and Head and Neck Surgical Oncology (2 papers). Marion Chevrier is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Ocular Oncology and Treatments (3 papers) and Head and Neck Surgical Oncology (2 papers). Marion Chevrier collaborates with scholars based in France, Singapore and Germany. Marion Chevrier's co-authors include Jinmiao Chen, Michelle Goh, Xiaomeng Zhang, Kok Siong Ang, Hoa Thi Tran, Josephine Lum, C. Melción, A. Cordier, Lysiane Richert and Ido Amit and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Immunology.

In The Last Decade

Marion Chevrier

19 papers receiving 959 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A benchmark of batch-effect correction methods for single-cell RNA sequencing data

2020 624 citations Hoa Thi Tran, Kok Siong Ang et al. Genome biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marion Chevrier France	10	610	291	181	127	122	20	974
Michelle Goh Australia	16	569 0.9×	187 0.6×	147 0.8×	152 1.2×	121 1.0×	43	1.1k
Anna Arutyunyan United States	8	570 0.9×	220 0.8×	134 0.7×	125 1.0×	74 0.6×	10	825
Alma Andersson Sweden	11	951 1.6×	269 0.9×	238 1.3×	131 1.0×	180 1.5×	18	1.3k
Marcory C. R. F. van Dijk Netherlands	19	331 0.5×	177 0.6×	132 0.7×	363 2.9×	33 0.3×	29	910
Manjunath Kustagi United States	9	659 1.1×	313 1.1×	137 0.8×	120 0.9×	21 0.2×	11	1.1k
Rasa Elmentaite United Kingdom	6	601 1.0×	233 0.8×	127 0.7×	108 0.9×	96 0.8×	7	790
Pau Badia-i-Mompel Germany	6	442 0.7×	136 0.5×	76 0.4×	69 0.5×	46 0.4×	9	695
Jordi Martorell‐Marugán Spain	16	469 0.8×	176 0.6×	234 1.3×	91 0.7×	13 0.1×	31	845
Tamim Abdelaal Netherlands	11	668 1.1×	280 1.0×	126 0.7×	98 0.8×	183 1.5×	28	887
Jamie Guenthoer United States	11	696 1.1×	239 0.8×	218 1.2×	240 1.9×	71 0.6×	18	1.0k

Countries citing papers authored by Marion Chevrier

Since Specialization

Citations

This map shows the geographic impact of Marion Chevrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Chevrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Chevrier more than expected).

Fields of papers citing papers by Marion Chevrier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Chevrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Chevrier. The network helps show where Marion Chevrier may publish in the future.

Co-authorship network of co-authors of Marion Chevrier

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Chevrier. A scholar is included among the top collaborators of Marion Chevrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Chevrier. Marion Chevrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chevrier, Marion, Jean‐Sébastien Frenel, Frédéric Guyon, et al.. (2025). Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database. Gynecologic Oncology. 201. 17–25.

Ray‐Coquard, Isabelle, Laurence Gladieff, Christophe Pomel, et al.. (2023). Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse. International Journal of Gynecological Cancer. 33(4). 577–584. 1 indexed citations

Mariani, Pascale, François‐Clément Bidard, Aurore Rampanou, et al.. (2023). Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma. Annals of Surgery. 278(4). e827–e834. 10 indexed citations

Alcantara, Marion, Marion Chevrier, Fabrice Jardin, et al.. (2023). Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R-MPV for patients with a newly diagnosed primary central nervous system lymphoma (PCNSL).. Journal of Clinical Oncology. 41(16_suppl). 7566–7566. 1 indexed citations

Rodrigues, Manuel, Pierre Loap, Coraline Dubot, et al.. (2022). Combination of nivolumab with chemoradiotherapy for locally advanced cervical cancer: NiCOL phase I trial.. Journal of Clinical Oncology. 40(16_suppl). 5534–5534. 6 indexed citations

Beddok, Arnaud, Marion Chevrier, Valentin Calugaru, et al.. (2021). Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemic. International Journal of Radiation Biology. 97(10). 1436–1440. 1 indexed citations

Rouers, Angéline, Ramapraba Appanna, Marion Chevrier, et al.. (2021). CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function. iScience. 24(5). 102482–102482. 11 indexed citations

Bouleuc, Carole, Alexia Savignoni, Marion Chevrier, et al.. (2020). A Question Prompt List for Advanced Cancer Patients Promoting Advance Care Planning: A French Randomized Trial. Journal of Pain and Symptom Management. 61(2). 331–341.e8. 20 indexed citations

Tran, Hoa Thi, Kok Siong Ang, Marion Chevrier, et al.. (2020). A benchmark of batch-effect correction methods for single-cell RNA sequencing data. Genome biology. 21(1). 12–12. 624 indexed citations breakdown →

10.

Dress, Regine J., Charles‐Antoine Dutertre, Amir Giladi, et al.. (2019). Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage. Nature Immunology. 20(7). 852–864. 154 indexed citations

11.

Vasseur, Antoine, Luc Cabel, Olivier Trédan, et al.. (2019). Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET). Angiogenesis. 23(2). 193–202. 8 indexed citations

12.

Brisse, Hervé J., Paul Fréneaux, Laurence Desjardins, et al.. (2019). Management of advanced uni‐ or bilateral retinoblastoma with macroscopic optic nerve invasion. Pediatric Blood & Cancer. 67(1). e27998–e27998. 13 indexed citations

13.

Chevrier, Marion, Vipin Narang, Josephine Lum, et al.. (2019). RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity. Journal of Virology. 93(14). 11 indexed citations

14.

Chevrier, Marion, Alain Fourquet, É. Costa, et al.. (2017). Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy. International Journal of Radiation Oncology*Biology*Physics. 98(1). 206–214. 22 indexed citations

15.

Brisse, Hervé J., Paul Fréneaux, Livia Lumbroso‐Le Rouic, et al.. (2017). Management of uni- or bilateral retinoblastoma with radiologic optic nerve invasion at diagnosis.. Journal of Clinical Oncology. 35(15_suppl). 10551–10551. 1 indexed citations

16.

Bidard, François‐Clément, Étienne Brain, William Jacot, et al.. (2016). First line hormone therapy vs chemotherapy for HR+ HER2- metastatic breast cancer in the phase III STIC CTC trial: clinical choice and validity of CTC count. Annals of Oncology. 27. vi69–vi69. 1 indexed citations

17.

Ghesquières, Hervé, Caroline Houillier, Olivier Chinot, et al.. (2016). Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network. Blood. 128(22). 785–785. 30 indexed citations

18.

Chevrier, Marion, N. Fournier‐Bidoz, F. Campana, et al.. (2016). Postmastectomy Electron Beam Radiation Therapy (PMERT): Efficacy and Toxicity. International Journal of Radiation Oncology*Biology*Physics. 96(2). E40–E40. 1 indexed citations

19.

Serban, Monica, et al.. (2010). MO‐E‐BRA‐02: Computer Aided Design and Monte Carlo Validation of a Patient‐Specific Co‐60 TBI Treatment Unit. Medical Physics. 37(6Part26). 3353–3353. 1 indexed citations

20.

Chevrier, Marion, et al.. (1991). Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats. Toxicology and Applied Pharmacology. 111(2). 263–278. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact